Recital 1, Regulation (EU) 2021/2071

In force

On 30 January 2021, the Commission adopted Implementing Regulation (EU) 2021/111 [OJ L 31 I, 30.1.2021, p. 1.] making the exportation of COVID-19 vaccines as well as active substances, including master and working cell banks, used to manufacture these vaccines, subject to the production of an export authorisation, pursuant to Article 5 of Regulation (EU) 2015/479, for a period of six weeks. Hereafter, on 12 March 2021, the Commission adopted Implementing Regulation (EU) 2021/442 [OJ L 85, 12.3.2021, p. 190.] making the exportation of the same products subject to an export authorisation until 30 June 2021, pursuant to Article 6 of Regulation (EU) 2015/479.